特集 : 国別レポートが13,000件から検索可能になりました!

特集 : 海外市場の委託調査がセミカスタムベースでお手軽にできます

株式会社グローバルインフォメーション
TEL: 044-952-0102
市場調査レポート

コンパニオン診断の世界市場:動向・予測・競合分析

Companion Diagnostic Market Report: Trends, Forecast, and Competitive Analysis

発行 Lucintel - Semi-Custom Reports 商品コード 945072
出版日 ページ情報 英文
納期: 約3~5週間
価格
本日の銀行送金レート: 1USD=107.57円で換算しております。

【セミカスタムオーダー型の調査レポート】
当レポートは、目次内の調査項目について *追加/変更ご要望を反映させる事も可能です。
ご注文を承った時点からLucintel社データベースより最新のデータを抽出・分析・編集を行うため、納品には約3~5週間程度を要します。
* ご要望が無い場合は目次通りの内容構成にて作成となります。
* ご要望項目の分量によりましては追加費用が発生する場合がございます。

コンパニオン診断の世界市場:動向・予測・競合分析 Companion Diagnostic Market Report: Trends, Forecast, and Competitive Analysis
出版日: 2020年06月01日 ページ情報: 英文
概要

世界のコンパニオン診断の市場は予測期間中20%のCAGRで成長すると予測されています。規制ガイドラインの改善、標的治療薬のニーズの拡大、癌の発症率の増加、診断検査開発における提携・協力関係の増加などの要因が同市場の成長を推進しています。

当レポートでは、世界のコンパニオン診断の市場を調査し、市場の背景・概要、サプライチェーン、産業推進因子と課題、各種区分・地域・主要国別の動向と市場規模の推移・予測、競合環境と市場シェア、製品ポートフォリオ、成長機会・成功戦略の分析、主要企業のプロファイルなどをまとめています。

第1章 エグゼクティブサマリー

第2章 市場の背景・分類

  • イントロダクション・背景・分類
  • サプライチェーン
  • 産業推進因子・課題

第3章 市場動向・予測分析

  • マクロ経済動向・予測
  • 世界市場の動向・予測
  • 世界市場:製品・サービス別
    • アッセイ・試薬
    • ソフトウェア・サービス
  • 世界市場:技術別
    • ポリメラーゼ連鎖反応(PCR)
    • 免疫組織化学(IHC)
    • In Situハイブリダイゼーション(ISH)
    • 次世代シーケンシング
    • その他
  • 世界市場:適応症別
    • 腫瘍
    • 神経疾患
    • その他
  • 世界市場:エンドユーザー別
    • 製薬・バイオ医薬品企業
    • リファレンスラボ
    • その他

第4章 市場動向・予測分析:地域別

  • 地域別市場
  • 北米
  • 欧州
  • アジア太平洋
  • その他の地域
    • 製品・サービス別
    • 技術別
    • 適応症別
    • エンドユーザー別

第5章 競合分析

  • 製品ポートフォリオ分析
  • 市場シェア分析
  • 運用統合
  • 地域的リーチ
  • ポーターのファイブフォース分析

第6章 成長機会・戦略分析

  • 成長機会の分析
  • 新興動向
  • 戦略分析

第7章 主要企業のプロファイル

  • F. Hoffmann-La Roche
  • Agilent Technologies
  • Qiagen
  • Thermo Fisher Scientific
  • Abbott Laboratories
  • Biomerieux
  • Danaher
  • Illumina
  • Myriad Genetics
  • Arup Laboratories
目次

The future of the companion diagnostic market looks promising with opportunities in the pharmaceutical and biopharmaceutical companies, and reference lab. The global companion diagnostic market is expected to grow with a CAGR of 20% from 2019 to 2024. The major growth drivers for this market are improvements in regulatory guidelines, growing need for targeted therapies, rising cancer incidence , and increasing collaborations and partnerships for companion diagnostics test development.

A report of more than 150 pages developed to help in your business decisions. Sample figures with some insights are shown below. To learn the scope of, benefits, companies researched and other details of companion diagnostic market report download the report brochure.

The study includes the companion diagnostic market size and forecast for the global companion diagnostic market through 2024, segmented by product and service, technology, indication, end use, and region as follows:

By Product and Service [$M shipment analysis for 2013 - 2024]:

  • Assays & Reagents
  • Software & Services

By Technology [$M shipment analysis for 2013 - 2024]:

  • Polymerase Chain Reaction (PCR)
  • Immunohistochemistry (IHC)
  • In Situ Hybridization (ISH)
  • Next-generation Sequencing
  • Other Technologies

By Indication [$M shipment analysis for 2013 - 2024]:

  • Oncology
  • Neurology
  • Other Indications

By End Use [$M shipment analysis for 2013 - 2024]:

  • Pharmaceutical and Biopharmaceutical Companies
  • Reference Lab
  • Other End Users

By Region [$M shipment analysis for 2013 - 2024]:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • United Kingdom
    • Germany
    • France
    • Italy
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
  • Rest of the World
    • Brazil

Some of the companion diagnostics companies profiled in this report include F. Hoffmann-La Roche, Agilent Technologies, Qiagen, Thermo Fisher Scientific, Abbott Laboratories, Biomerieux, Danaher, Illumina, Myriad Genetics, Arup Laboratories, Sysmex, Hologic, Novartis, Almac Group, and Abnova.

Some of the features of "Global Companion Diagnostic market 2019-2024: Trends, Forecast, and Opportunity Analysis" include:

  • Market size estimates: Global companion diagnostic market size estimation in terms of value ($M) shipment.
  • Trend and forecast analysis: Market trend (2013-2018) and forecast (2019-2024) by segments and region.
  • Segmentation analysis: Global market size by various applications such as by product and service, technology, indication, end use, and region.
  • Regional analysis: Global companion diagnostic market breakdown by North America, Europe, Asia Pacific, and the Rest of the World.
  • Growth opportunities: Analysis on growth opportunities in different applications and regions for companion diagnostics in the global companion diagnostic market.
  • Strategic analysis: This includes M&A, new product development, and competitive landscape for, companion diagnostics in the global companion diagnostic market.
  • Analysis of competitive intensity of the industry based on Porter's Five Forces model.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising potential, high-growth opportunities for the global companion diagnostic market by product and service (assays and reagents and software and services), technology (polymerase chain reaction (PCR), immunohistochemistry (IHC), in situ hybridization (ISH) , next-generation sequencing, and other technologies), indication (oncology, neurology, others, and other indications), end use (pharmaceutical and biopharmaceutical companies, reference lab, and other end user), and region (North America, Europe, Asia-Pacific, and ROW)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which regions will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the drivers and challenges of the companion diagnostic market?
  • Q.5. What are the business risks and threats to the companion diagnostic market?
  • Q.6. What are emerging trends in this companion diagnostic market and the reasons behind them?
  • Q.7. What are some changing demands of customers in the companion diagnostic market?
  • Q.8. What are the new developments in the companion diagnostic market? Which companies are leading these developments?
  • Q.9. Who are the major players in this companion diagnostic market? What strategic initiatives are being implemented by key players for business growth?
  • Q.10. What are some of the competitive products and processes in this companion diagnostics area and how big of a threat do they pose for loss of market share via material or product substitution?
  • Q.11. What M & A activities have taken place in the last 5 years in companion diagnostic market?

1. Executive Summary

2. Market Background and Classifications

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2013 to 2024

  • 3.1: Macroeconomic Trends and Forecast
  • 3.2: Global Companion Diagnostic Market: Trends and Forecast
  • 3.3: Global Companion Diagnostic Market by Product and Service
    • 3.3.1: Assays & Reagents
    • 3.3.2: Software & Services
  • 3.4: Global Companion Diagnostic Market by Technology
    • 3.4.1: Polymerase Chain Reaction (PCR)
    • 3.4.2: Immunohistochemistry (IHC)
    • 3.4.3: In Situ Hybridization (ISH)
    • 3.4.4: Next-generation Sequencing
    • 3.4.5: Other Technologies
  • 3.5: Global Companion Diagnostic Market by Indication
    • 3.5.1: Oncology
    • 3.5.2: Neurology
    • 3.5.3: Others
  • 3.6: Global Companion Diagnostic Market by End Use
    • 3.6.1: Pharmaceutical and Biopharmaceutical Companies
    • 3.6.2: Reference Lab
    • 3.6.3: Other End Users

4. Market Trends and Forecast Analysis by Region

  • 4.1: Global Companion Diagnostic Market by Region
  • 4.2: North American Companion Diagnostic Market
    • 4.2.1: Market by Product and Service: Assays & Reagents and Software & Services
    • 4.2.2: Market by Technology: Polymerase Chain Reaction (PCR), Immunohistochemistry (IHC), In Situ Hybridization (ISH), Next-generation Sequencing, and Other Technologies
    • 4.2.3: Market by Indication: Oncology, Neurology, and Others
    • 4.2.4: Market by End Use: Pharmaceutical and Biopharmaceutical Companies, Reference Lab, and Other End Users
  • 4.3: European Companion Diagnostic Market
    • 4.3.1: Market by Product and Service: Assays & Reagents and Software & Services
    • 4.3.2: Market by Technology: Polymerase Chain Reaction (PCR), Immunohistochemistry (IHC), In Situ Hybridization (ISH), Next-generation Sequencing, and Other Technologies
    • 4.3.3: Market by Indication: Oncology, Neurology, and Others
    • 4.3.4: Market by End Use: Pharmaceutical and Biopharmaceutical Companies, Reference Lab, and Other End Users
  • 4.4: APAC Companion Diagnostic Market
    • 4.4.1: Market by Product and Service: Assays & Reagents and Software & Services
    • 4.4.2: Market by Technology: Polymerase Chain Reaction (PCR), Immunohistochemistry (IHC), In Situ Hybridization (ISH), Next-generation Sequencing, and Other Technologies
    • 4.4.3: Market by Indication: Oncology, Neurology, and Others
    • 4.4.4: Market by End Use: Pharmaceutical and Biopharmaceutical Companies, Reference Lab, and Other End Users
  • 4.5: ROW Companion Diagnostic Market
    • 4.5.1: Market by Product and Service: Assays & Reagents and Software & Services
    • 4.5.2: Market by Technology: Polymerase Chain Reaction (PCR), Immunohistochemistry (IHC), In Situ Hybridization (ISH), Next-generation Sequencing, and Other Technologies
    • 4.5.3: Market by Indication: Oncology, Neurology, and Others
    • 4.5.4: Market by End Use: Pharmaceutical and Biopharmaceutical Companies, Reference Lab, and Other End Users

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Market Share Analysis
  • 5.3: Operational Integration
  • 5.4: Geographical Reach
  • 5.5: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for Global Companion Diagnostic Market by Product and Service
    • 6.1.2: Growth Opportunities for Global Companion Diagnostic Market by Technology
    • 6.1.3: Growth Opportunities for Global Companion Diagnostic Market by Indication
    • 6.1.4: Growth Opportunities for Global Companion Diagnostic Market by End Use
    • 6.1.5: Growth Opportunities for Global Companion Diagnostic Market by Region
  • 6.2: Emerging Trends in Global Companion Diagnostic Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of Global Companion Diagnostic Market
    • 6.3.3: Mergers, Acquisitions and Joint Ventures in the Global Companion Diagnostic Market

7. Company Profiles of Leading Players

  • 7.1: F. Hoffmann-La Roche
  • 7.2: Agilent Technologies
  • 7.3: Qiagen
  • 7.4: Thermo Fisher Scientific
  • 7.5: Abbott Laboratories
  • 7.6: Biomerieux
  • 7.7: Danaher
  • 7.8: Illumina
  • 7.9: Myriad Genetics
  • 7.10: Arup Laboratories